IP Library Granted Patent US 9,884,190
Granted Patent B2
US 9,884,190 · App. 14/879,943 · Granted Feb 6, 2018

Surgical method for implantable head mounted neurostimulation system for head pain

Inventors: Kenneth Lyle Reed (Dallas, TX); Robert Raymond Bulger (Dallas, TX); Michael Steven Colvin (Newbury Park, CA); Claire Denault (Dallas, TX)
Assignee: Syntilla Medical LLC
A61N1/36075A61N1/0526A61N1/0551A61N1/0504A61N1/3787A61N1/37229A61N1/37247
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,190
App. No.
14/879,943
Granted
Feb 6, 2018
Kind
B2
Abstract

A method for subcutaneously treating pain in a patient includes first providing a neurostimulator with an IPG body and at least a primary integral lead with electrodes disposed thereon. A primary incision is opened to expose the subcutaneous region below the dermis in a selected portion of the body. A pocket is then opened for the IPG through the primary incision and the primary integral lead is inserted through the primary incision and routed subcutaneously to a first desired nerve region along a first desired path. The IPG is disposed in the pocket through the primary incision. The primary incision is then closed and the IPG and the electrodes activated to provide localized stimulation to the desired nerve region and at least one of the nerves associated therewith to achieve a desired pain reduction response from the patient.

Claims (12)

1. A method for treating patients with migraine headaches, comprising the steps of:

subcutaneously implanting at least one neurostimulator control system through an incision in the cranial region, which neurostimulator control system includes a main body disposed proximate the incision having a processor disposed therein and an interface interfacing to at least one integrated stimulating lead, and the at least one integrated stimulating lead having a proximal end connected to the interface and an array of electrodes disposed along the length of the at least one integrated stimulating lead proximate the distal end thereof and interfaced through internal wires to the processor through the interface, the step of implanting further extending the distal end of the integrated stimulating lead subcutaneously from the neurostimulator control system to the frontal cranial region so that at least one of the electrodes is proximate and over a nerve; and

applying, after extending the distal end of the at least one integrated stimulating lead, at least one stimulating signal by the processor in the main body through the internal wires in the at least one integrated stimulating lead to the electrode proximate the at least one nerve, thereby at least in part alleviating pain associated with migraine headaches;

wherein the at least one nerve is selected from at least one of the body, branches and roots of at least one of the supraorbital nerves.

2. The method of claim 1 , wherein the incision is made proximate the parietal bone.

3. The method of claim 2 , wherein the incision is distal and above the pinna.

4. The method of claim 1 , wherein a subcutaneous pocket is created through the incision to contain the neurostimulator control system.

5. The method of claim 1 , wherein the neurostimulator control system includes a power source and an internal communication system.

6. The method of claim 5 , and further comprising interfacing an external communication system with the internal communication system to transmit signals thereto, wherein the transmission of signals to the internal communication system causes the processor to apply the at least one stimulating signal.

7. The method of claim 1 , wherein the interface interfaces to at least another integrated stimulating lead, and the at least another integrated stimulating lead having a proximal end connected to the interface and an array of electrodes disposed along the length of the at least another integrated stimulating lead proximate the distal end thereof and interfaced through internal wires to the processor through the interface, the step of implanting further extending the distal end of the at least another integrated stimulating lead subcutaneously from the neurostimulator control system to the occipital region so that at least one of the electrodes thereof is proximate and over a nerve and wherein the nerve is selected from at least one of the body, branches and roots of at least one of the occipital nerves.

8. The method of claim 1 , wherein the incision is closed prior to the step of applying the at least one stimulating signal.

9. The method of claim 1 , wherein the at least one integrated stimulating lead includes a second array of electrodes with at least one of the electrodes in the second array disposed over at least one nerve which is selected from at least one of the body, branches and roots of at least one of the auriculo-temporal nerves.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2021
From: NUXCEL, INC.
To: SHIRATRONICS, INC.
Reel/Frame 057689/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2019
From: SYNTILLA MEDICAL LLC.
To: NUXCEL, INC.
Reel/Frame 048557/0589 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2015
From: REED, KENNETH LYLE; BULGER, ROBERT RAYMOND; COLVIN, MICHAEL STEVEN; DENAULT, CLAIRE
To: SYNTILLA MEDICAL LLC
Reel/Frame 036788/0580 →
Continuity (4)
Continuation In Part 14717912 · May 20, 2015
Continuation 14460139 · Aug 14, 2014
Provisional Application 61894795 · Oct 23, 2013
Related Publication 20160030746A1 · Feb 4, 2016